Clinical Trial

Morning Versus Evening Patching in Childhood Amblyopia

Completed
View on ClinicalTrials.gov →
Summary
To determine whether the time of day at which daily occlusion therapy is administered-morning, with 2 hours of patching completed within 07:00-10:00, versus evening, with 2 hours completed within 17:00-20:00-affects visual-acuity improvement in the amblyopic eye in children with unilateral amblyopia. Rationale: While occlusion therapy remains the mainstay for treatment of childhood amblyopia, existing trials have focused on patching duration, not on the timing of occlusion. Diurnal or chronobiological factors - such as fluctuations in neuroplasticity, attention, compliance, or visual demand during the day - may influence the efficacy of patching. Understanding whether timing matters could help optimize occlusion therapy, improve outcomes, and reduce treatment burden.
Protocol Amendment History 4 changes
critical Completed without a posted recruiting period 2026-08-05
notable Enrollment reduced: 100 -> 84 participants 2026-08-05
notable Primary completion pushed: 2026-06-14 -> 2026-08-01 2026-08-05
minor Completion pushed: 2026-06-14 -> 2026-08-01 2026-08-05
Trial Details
NCT Number NCT07294599
Lead Sponsor Yarmouk University
Conditions Amblyopia
Enrollment 84 participants
Start Date 2025-12-14
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-04